5/30/2023 0 Comments Relive company![]() ![]() The startup will actively seek strategic partnerships for technology transfers and licensing opportunities in ASEAN, South America, the Middle East, Mexico, and Japan to continuously expand the market globally. In China, ReLive has completed the construction of a production facility for Spherox's, and the company plans to expeditiously carry out the required bridging clinical trials before launching China's first approved cell therapy for cartilage repair. "ReLive will independently research and develop cost-effective tissue engineering products based on a combination of stem cell technology and 3D printing of scaffolds, targeting treatments of hyaline cartilage, osteocartilage, meniscus in orthopedics and sports medicine, and external ear reconstruction in plastic surgery", said Dr Xing Zhao, ReLive's founder, Chairman and CEO. Companys authorized capital stands at Rs 10.0 lakhs and has 50.0 paid-up. G&G Capital serves as the exclusive financial advisor. Its a public unlisted company and is classified ascompany limited by shares. Series A was led by Shanghai Healthcare Capital (SHC), with contributions from two existing angel investors, Indaco Capital and Jiuyo Capital, and a new joiner Watson Capital. ReLive plans to use the fund for R&D, licensing, manufacturing, distributions, and other operational needs in China, US and Europe. Simultaneously with the acquisition, China-based startup ReLive also completed its Series A financing of $36 million to fund the company's global ambition. Unless the debt settlement company settles all or most of your debts, the built up penalties and fees on the unsettled debts may wipe out any savings the debt settlement company achieves on the debts it settles. Clip, Edit, Share, and Relive your gaming moments. Working with a debt settlement company may lead to a creditor filing a debt collection lawsuit against you. It was authorised by the European Medicines Agency (EMA) for distribution across Europe in 2017. Medal is the best way to record, clip, edit, and share your gaming clips and videos. "Spherox" is one of the only two authorised cell therapy for the regenerative treatment of articular cartilage defects globally. ReLive Biotechnologies, founded in 2021, has completed the acquisition of all operating assets of Germany-listed biotech company Co.Don AG, taking over the global patent rights of its flagship products "Spherox" and "Chondrosphere". ![]()
0 Comments
Leave a Reply. |